A 48-year-old woman with biopsy-proven cirrhosis (primary biliary cholangitis) presents with acute-onset confusion, asterixis, and fetor hepaticus. She denies recent alcohol use or NSAIDs. Serum ammonia is 180 µmol/L (normal <50). Abdominal ultrasound shows no ascites. She is afebrile; WBC 6.5 × 10^9^/L, creatinine 0.9 mg/dL. What is the most appropriate next step in management?

Explanation

## Clinical Scenario Interpretation This patient has **hepatic encephalopathy (HE)** with markedly elevated ammonia (180 µmol/L). The key clinical question is: **What is the most appropriate next step in a cirrhotic with HE but NO ascites (clinically or on ultrasound), no fever, and normal WBC?** ## High-Yield: Managing Hepatic Encephalopathy — Precipitant Search vs. Empiric Paracentesis **Lactulose + rifaximin are the immediate first-line treatments for HE.** The precipitant in this case must be identified, but the clinical picture does NOT mandate empiric paracentesis when: - **No ascites** is detected clinically or on ultrasound - **No fever** (afebrile) - **Normal WBC** (6.5 × 10⁹/L) - **No peritoneal signs** SBP requires ascites by definition (PMN ≥250 cells/µL in ascitic fluid). Without ascites, SBP cannot exist, and diagnostic paracentesis has no fluid to sample. Ultrasound is a reliable screening tool for clinically significant ascites volumes sufficient for SBP to occur. ## Management Algorithm for Hepatic Encephalopathy | Priority | Action | |---|---| | **Immediate** | Lactulose 15–30 mL BD–TID (target 2–3 stools/day) + Rifaximin 550 mg BD | | **Identify precipitants** | Infection, GI bleed, constipation, dietary protein excess, drugs, electrolyte disturbance | | **Paracentesis** | Only if ascites develops or is detected on imaging | | **Empiric antibiotics** | Only if SBP is suspected (ascites + fever/peritoneal signs) | ## Key Point: SBP Requires Ascites **Source: Harrison's Principles of Internal Medicine, 21e, Ch. 297** SBP is defined as infection of ascitic fluid in the absence of a surgically treatable source. It **cannot occur without ascites**. The classic teaching that "paracentesis is mandatory in all cirrhotic patients with HE" applies specifically to those **with ascites** — not to patients with no ascites on ultrasound and no clinical signs of infection. Performing paracentesis without ascites is: - Technically not feasible (no fluid to tap) - Not indicated per AASLD/EASL guidelines - Potentially harmful (risk of bowel perforation with blind tap) ## Ammonia-Lowering Therapy **Lactulose** (first-line): - Non-absorbable disaccharide → acidifies colon → traps ammonia as NH₄⁺ - Titrate to 2–3 bowel movements daily - Dose: 15–30 mL BD–TID orally or via NG tube; rectal enemas if obtunded **Rifaximin** (adjunct/second-line): - Non-absorbed antibiotic; reduces ammonia-producing gut bacteria - 550 mg BD; synergistic with lactulose - Preferred over neomycin (superior safety profile, no nephrotoxicity) ## Clinical Pearl **The absence of ascites on ultrasound effectively excludes SBP.** In a cirrhotic with HE, no fever, normal WBC, and no ascites, the correct next step is to immediately initiate lactulose and rifaximin and search for other precipitants (GI bleed, constipation, electrolyte disturbance, drugs). Paracentesis is reserved for when ascites develops. ## Warning: Common Trap ~~"All cirrhotic patients with HE need paracentesis regardless of ascites"~~ This is **incorrect** when applied to patients with no ascites on imaging and no clinical signs of infection. Paracentesis is indicated in HE **with ascites** to rule out SBP as a precipitant — not in the absence of ascites.